ALZN
Price
$2.90
Change
-$0.04 (-1.37%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
2.32M
VRAX
Price
$0.79
Change
-$0.01 (-1.25%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
3.3M
Interact to see
Advertisement

ALZN vs VRAX

Header iconALZN vs VRAX Comparison
Open Charts ALZN vs VRAXBanner chart's image
Alzamend Neuro
Price$2.90
Change-$0.04 (-1.37%)
Volume$2.32K
Capitalization2.32M
Virax Biolabs Group
Price$0.79
Change-$0.01 (-1.25%)
VolumeN/A
Capitalization3.3M
ALZN vs VRAX Comparison Chart in %
Loading...
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALZN vs. VRAX commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALZN is a Buy and VRAX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (ALZN: $2.93 vs. VRAX: $0.80)
Brand notoriety: ALZN and VRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALZN: 14% vs. VRAX: 63%
Market capitalization -- ALZN: $2.32M vs. VRAX: $3.3M
ALZN [@Biotechnology] is valued at $2.32M. VRAX’s [@Biotechnology] market capitalization is $3.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $312.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALZN’s FA Score shows that 0 FA rating(s) are green whileVRAX’s FA Score has 0 green FA rating(s).

  • ALZN’s FA Score: 0 green, 5 red.
  • VRAX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALZN and VRAX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALZN’s TA Score shows that 3 TA indicator(s) are bullish while VRAX’s TA Score has 4 bullish TA indicator(s).

  • ALZN’s TA Score: 3 bullish, 3 bearish.
  • VRAX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ALZN and VRAX are a good buy in the short-term.

Price Growth

ALZN (@Biotechnology) experienced а -1.35% price change this week, while VRAX (@Biotechnology) price change was -2.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.95%. For the same industry, the average monthly price growth was +32.23%, and the average quarterly price growth was +16.56%.

Reported Earning Dates

ALZN is expected to report earnings on Mar 10, 2025.

VRAX is expected to report earnings on Aug 12, 2022.

Industries' Descriptions

@Biotechnology (+1.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRAX($3.3M) has a higher market cap than ALZN($2.32M). VRAX YTD gains are higher at: -64.378 vs. ALZN (-71.935). ALZN has higher annual earnings (EBITDA): -4.16M vs. VRAX (-6.43M). VRAX has more cash in the bank: 7.29M vs. ALZN (3.36M). ALZN has less debt than VRAX: ALZN (301K) vs VRAX (380K). VRAX has higher revenues than ALZN: VRAX (84.9K) vs ALZN (0).
ALZNVRAXALZN / VRAX
Capitalization2.32M3.3M70%
EBITDA-4.16M-6.43M65%
Gain YTD-71.935-64.378112%
P/E RatioN/AN/A-
Revenue084.9K-
Total Cash3.36M7.29M46%
Total Debt301K380K79%
TECHNICAL ANALYSIS
Technical Analysis
ALZNVRAX
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 17 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TCRX1.680.23
+15.86%
TScan Therapeutics
ZKH3.180.05
+1.60%
ZKH Group Limited
TNFA0.14N/A
+1.30%
TNF Pharmaceuticals Inc.
GWRE237.45-0.95
-0.40%
Guidewire Software
THS20.83-0.17
-0.81%
Treehouse Foods

ALZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALZN has been loosely correlated with SRPT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ALZN jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALZN
1D Price
Change %
ALZN100%
-0.68%
SRPT - ALZN
49%
Loosely correlated
+0.58%
VRAX - ALZN
43%
Loosely correlated
+5.45%
SNSE - ALZN
41%
Loosely correlated
+5.09%
BPMUF - ALZN
36%
Loosely correlated
N/A
SILO - ALZN
33%
Loosely correlated
+2.39%
More

VRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRAX has been loosely correlated with ALZN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if VRAX jumps, then ALZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRAX
1D Price
Change %
VRAX100%
+5.45%
ALZN - VRAX
43%
Loosely correlated
-0.68%
SNGX - VRAX
36%
Loosely correlated
-19.39%
GOVX - VRAX
35%
Loosely correlated
+3.11%
NTRB - VRAX
31%
Poorly correlated
+1.04%
PTGX - VRAX
30%
Poorly correlated
+0.60%
More